Julie Janner

763 total citations
20 papers, 323 citations indexed

About

Julie Janner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Julie Janner has authored 20 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Julie Janner's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (9 papers) and Asthma and respiratory diseases (4 papers). Julie Janner is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (9 papers) and Asthma and respiratory diseases (4 papers). Julie Janner collaborates with scholars based in Denmark, United Kingdom and Spain. Julie Janner's co-authors include Jørgen Vestbo, Eva Prescott, Nina Godtfredsen, Steen Ladelund, Pablo Alonso‐Coello, Alexander G. Mathioudakis, Thérèse Lapperre, Josefin Eklöf, Charlotte Suppli Ulrik and Jens‐Ulrik Stæhr Jensen and has published in prestigious journals such as PLoS ONE, Clinical Microbiology and Infection and Respiratory Medicine.

In The Last Decade

Julie Janner

17 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Janner Denmark 10 159 99 60 41 40 20 323
Lucas Boeck Switzerland 14 231 1.5× 40 0.4× 78 1.3× 147 3.6× 37 0.9× 29 432
Yu Il Kim South Korea 12 194 1.2× 25 0.3× 66 1.1× 101 2.5× 18 0.5× 27 394
Melih Hulusi Us Türkiye 9 62 0.4× 86 0.9× 29 0.5× 32 0.8× 38 0.9× 39 299
Deepa Raghavan United States 8 251 1.6× 23 0.2× 79 1.3× 41 1.0× 22 0.6× 14 346
Giulia Ghidoni Italy 11 118 0.7× 38 0.4× 64 1.1× 55 1.3× 14 0.3× 18 313
Aziz Gümüş Türkiye 11 122 0.8× 49 0.5× 41 0.7× 29 0.7× 35 0.9× 44 289
Rohan Thompson United States 10 151 0.9× 12 0.1× 37 0.6× 110 2.7× 38 0.9× 28 319
Rik De Decker South Africa 6 156 1.0× 42 0.4× 35 0.6× 91 2.2× 29 0.7× 25 289
Christine Tuffery New Zealand 5 392 2.5× 34 0.3× 79 1.3× 150 3.7× 18 0.5× 9 488
Ludwig Ney Germany 9 60 0.4× 23 0.2× 26 0.4× 25 0.6× 24 0.6× 20 214

Countries citing papers authored by Julie Janner

Since Specialization
Citations

This map shows the geographic impact of Julie Janner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Janner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Janner more than expected).

Fields of papers citing papers by Julie Janner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Janner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Janner. The network helps show where Julie Janner may publish in the future.

Co-authorship network of co-authors of Julie Janner

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Janner. A scholar is included among the top collaborators of Julie Janner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Janner. Julie Janner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivapalan, Pradeesh, Josefin Eklöf, Jonas Bredtoft Boel, et al.. (2024). Inhaled corticosteroids andStenotrophomonas maltophiliain outpatients with chronic obstructive pulmonary disease: a retrospective cohort study. BMJ Open Respiratory Research. 11(1). e001929–e001929. 1 indexed citations
2.
Sivapalan, Pradeesh, Jonas Rutishauser, Charlotte Suppli Ulrik, et al.. (2021). Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials. Respiratory Research. 22(1). 155–155. 7 indexed citations
3.
4.
Sivapalan, Pradeesh, Niklas Rye Jørgensen, Alexander G. Mathioudakis, et al.. (2020). Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial. Respiratory Research. 21(1). 263–263. 2 indexed citations
5.
Janner, Julie, Camilla Bjørn Jensen, Lars Ängquist, et al.. (2020). Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. European Clinical Respiratory Journal. 7(1). 1757274–1757274. 22 indexed citations
6.
Mathioudakis, Alexander G., et al.. (2019). A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations. ERJ Open Research. 5(4). 136–2019. 14 indexed citations
7.
Eklöf, Josefin, Rikke Sørensen, Truls Sylvan Ingebrigtsen, et al.. (2019). Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Clinical Microbiology and Infection. 26(2). 227–234. 91 indexed citations
8.
Eklöf, Josefin, Rikke Sørensen, Truls Sylvan Ingebrigtsen, et al.. (2019). Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease. PA2887–PA2887.
9.
Mathioudakis, Alexander G., et al.. (2019). Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials. ERJ Open Research. 5(2). 72–2019. 19 indexed citations
10.
11.
Janner, Julie, et al.. (2014). Passive Smoking Is Associated with Poor Asthma Control during Pregnancy: A Prospective Study of 500 Pregnancies. PLoS ONE. 9(11). e112435–e112435. 11 indexed citations
12.
Janner, Julie, et al.. (2014). [Hypercalcaemia can be the only initial symptom of sarcoidosis].. PubMed. 176(9). 2 indexed citations
13.
Janner, Julie, Nina Godtfredsen, Steen Ladelund, Jørgen Vestbo, & Eva Prescott. (2012). High aortic augmentation index predicts mortality and cardiovascular events in men from a general population, but not in women. European Journal of Preventive Cardiology. 20(6). 1005–1012. 54 indexed citations
14.
Janner, Julie, David McAllister, Nina Godtfredsen, Eva Prescott, & Jørgen Vestbo. (2011). Is chronic obstructive pulmonary disease associated with increased arterial stiffness?. Respiratory Medicine. 106(3). 397–405. 12 indexed citations
15.
Janner, Julie, Nina Godtfredsen, Steen Ladelund, Jørgen Vestbo, & Eva Prescott. (2011). The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. Journal of Human Hypertension. 26(8). 476–484. 47 indexed citations
16.
Janner, Julie. (2009). Is COPD a risk factor for increased arterial stiffness?. Respiratory Medicine. 103. S5–S6.
17.
Janner, Julie, et al.. (2008). Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital. Scandinavian Journal of Infectious Diseases. 41(1). 26–32. 22 indexed citations
18.
Janner, Julie & Charlotte Suppli Ulrik. (2007). [New principles and possibilities in the treatment of asthma].. PubMed. 169(11). 995–7. 1 indexed citations
19.
Janner, Julie. (1964). [REPEATED SELF-MUTILATION OF A TRANSVESTITE].. PubMed. 94. 205–7. 1 indexed citations
20.
Janner, Julie & Adam C. Celio. (1962). Spätresultate nach Wiederbelebung durch sogenannte transthorakale Herzmassage. DMW - Deutsche Medizinische Wochenschrift. 87(17). 863–868. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucas Boeck Breakdown of academic impact, for papers by Yu Il Kim Breakdown of academic impact, for papers by Melih Hulusi Us Breakdown of academic impact, for papers by Deepa Raghavan Breakdown of academic impact, for papers by Giulia Ghidoni Breakdown of academic impact, for papers by Aziz Gümüş Breakdown of academic impact, for papers by Rohan Thompson Breakdown of academic impact, for papers by Rik De Decker Breakdown of academic impact, for papers by Christine Tuffery Breakdown of academic impact, for papers by Ludwig Ney
Rankless by CCL
2026